Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy | Zendy

Kumar Prabhash | Zendy; VijayM Patil | Zendy; Vanita Noronha | Zendy; Amit Joshi | Zendy; Vikas Talreja | Zendy; Sachin Dhumal | Zendy; Nandini Me | Zendy; Anuja Abhyankar | Zendy; Hollis Dsouza | Zendy; GunjeshKumar Singh | Zendy; Atanu Bhattacharjee | Zendy; Sarbani Ghosh-Laskar | Zendy; Prathamesh Pai | Zendy; Pankaj Chaturvedi | Zendy; Deepa Nair | Zendy; Devendra Chaukar | Zendy; Anil D‘Cruz | Zendy; Prakash Shetty | Zendy; Aliasgar Moiyadi | Zendy

Open Access

Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy

Author(s) -

Kumar Prabhash,

VijayM Patil,

Vanita Noronha,

Amit Joshi,

Vikas Talreja,

Sachin Dhumal,

Nandini Me,

Anuja Abhyankar,

Hollis Dsouza,

GunjeshKumar Singh,

Atanu Bhattacharjee,

Sarbani Ghosh-Laskar,

Prathamesh Pai,

Pankaj Chaturvedi,

Deepa Nair,

Devendra Chaukar,

Anil D‘Cruz,

Prakash Shetty,

Aliasgar Moiyadi

Publication year - 2020

Publication title -

cancer research statistics and treatment

Language(s) - English

Resource type - Journals

eISSN - 2590-3233

pISSN - 2590-3225

DOI - 10.4103/crst.crst_78_20

Subject(s) - esthesioneuroblastoma , medicine , cohort , adverse effect , oncology , chemotherapy , common terminology criteria for adverse events , proportional hazards model , retrospective cohort study , progression free survival , surgery , radiation therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research